Therapeutic Advances in Endocrinology and Metabolism

Scope & Guideline

Unlocking innovative therapies for metabolic challenges.

Introduction

Delve into the academic richness of Therapeutic Advances in Endocrinology and Metabolism with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2042-0188
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationTHER ADV ENDOCRINOL / Ther. Adv. Endocrinol. Metab.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Endocrinology and Metabolism' focuses on advancing the understanding and treatment of endocrine and metabolic disorders through innovative research and clinical practices. The following core areas summarize the main aims and scopes of the journal:
  1. Metabolic Disorders and Their Complications:
    The journal emphasizes research on metabolic disorders such as diabetes, obesity, and metabolic syndrome, exploring their pathophysiology, risk factors, and complications.
  2. Endocrine Disorders and Treatments:
    It covers a wide range of endocrine disorders, including thyroid diseases, adrenal disorders, and reproductive endocrinology, focusing on their diagnosis, management, and therapeutic interventions.
  3. Clinical Trials and Pharmacotherapy:
    The journal publishes findings from clinical trials on novel pharmacotherapies and interventions, providing insights into efficacy, safety, and real-world applications of treatments.
  4. Gender and Ethnicity in Metabolic Health:
    There is a consistent focus on the impact of gender and ethnicity on metabolic health and responses to treatment, highlighting the importance of personalized medicine.
  5. Emerging Technologies in Endocrinology:
    The journal explores the role of digital health technologies, continuous glucose monitoring, and telemedicine in managing endocrine and metabolic conditions.
Recent publications in the journal indicate a shift towards several trending and emerging themes that reflect current challenges and innovations in the field of endocrinology and metabolism. These include:
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    MAFLD has emerged as a significant focus area, highlighting the need to understand its implications in metabolic health and developing targeted therapies.
  2. Diabetes Technologies and Remote Monitoring:
    The increasing utilization of continuous glucose monitoring systems and telemedicine solutions for diabetes management marks a growing trend, emphasizing the role of technology in improving patient outcomes.
  3. Gender-Affirming Endocrine Care:
    Research on gender-affirming hormone therapy and its implications on metabolic health is gaining traction, reflecting broader societal changes and the need for inclusive healthcare practices.
  4. Socioeconomic Factors in Diabetes Management:
    Emerging studies are exploring the impact of socioeconomic status and social determinants on diabetes care and technology utilization, recognizing the multifaceted barriers patients face.
  5. Integrative and Multidisciplinary Approaches:
    There is a trend towards integrating multiple disciplines in the management of endocrine and metabolic disorders, including collaborations across specialties to address complex patient needs.

Declining or Waning

While the journal continues to thrive in various research areas, some themes have seen a decline in prominence over recent years. These waning scopes include:
  1. Traditional Nutritional Approaches to Diabetes Management:
    There has been a noticeable shift away from traditional dietary interventions for diabetes management, with less emphasis on strict dietary prescriptions and more focus on pharmacotherapy and technology-driven solutions.
  2. General Endocrine Disorders without Metabolic Context:
    Research focusing solely on general endocrine disorders without a metabolic context has declined, as the journal increasingly emphasizes the interconnections between metabolic and endocrine health.
  3. Basic Science Research without Clinical Applications:
    There has been a reduction in the publication of basic science studies that do not translate into clinical applications or therapeutic advancements, reflecting a trend towards more clinically relevant research.

Similar Journals

Journal of the ASEAN Federation of Endocrine Societies

Exploring Diabetes and Metabolism: A Gateway to Groundbreaking Research
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Enhancing understanding of metabolic disorders.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

BMC Endocrine Disorders

Advancing knowledge in endocrinology and metabolism.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

International Journal of Endocrinology

Exploring breakthroughs in diabetes and endocrine disorders.
Publisher: HINDAWI LTDISSN: 1687-8337Frequency:

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

Turkish Journal of Endocrinology and Metabolism

Connecting Researchers to Transform Endocrinology Practices
Publisher: AVESISSN: 1301-2193Frequency: 4 issues/year

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

Cardiovascular Endocrinology & Metabolism

Connecting the Dots Between Endocrine Function and Heart Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

Archives of Endocrinology Metabolism

Fostering innovation in endocrinology research.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Annals of Pediatric Endocrinology & Metabolism

Catalyzing discoveries in diabetes and metabolic disorders.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

DIABETES & METABOLISM

Pioneering Research in Endocrinology and Beyond
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

Austrian Journal of Clinical Endocrinology and Metabolism

Fostering collaboration in endocrinology and metabolism.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.